BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 21207297)

  • 1. Processing and analysis of GC/LC-MS-based metabolomics data.
    Want E; Masson P
    Methods Mol Biol; 2011; 708():277-98. PubMed ID: 21207297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data processing for mass spectrometry-based metabolomics.
    Katajamaa M; Oresic M
    J Chromatogr A; 2007 Jul; 1158(1-2):318-28. PubMed ID: 17466315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in applying chemometrics to LC-MS-based global metabolite profile data.
    Want E
    Bioanalysis; 2009 Jul; 1(4):805-19. PubMed ID: 21083139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic profiling of glucuronides in human urine by LC-MS/MS and partial least-squares discriminant analysis for classification and prediction of gender.
    Lutz U; Lutz RW; Lutz WK
    Anal Chem; 2006 Jul; 78(13):4564-71. PubMed ID: 16808466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint GC-MS and LC-MS platforms for comprehensive plant metabolomics: repeatability and sample pre-treatment.
    t'Kindt R; Morreel K; Deforce D; Boerjan W; Van Bocxlaer J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(29):3572-80. PubMed ID: 19762291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrolysis GC-MS-based metabolite fingerprinting for quality evaluation of commercial Angelica acutiloba roots.
    Tianniam S; Bamba T; Fukusaki E
    J Biosci Bioeng; 2010 Jan; 109(1):89-93. PubMed ID: 20129089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.
    Struck-Lewicka W; Kordalewska M; Bujak R; Yumba Mpanga A; Markuszewski M; Jacyna J; Matuszewski M; Kaliszan R; Markuszewski MJ
    J Pharm Biomed Anal; 2015; 111():351-61. PubMed ID: 25684700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation.
    Bijlsma S; Bobeldijk I; Verheij ER; Ramaker R; Kochhar S; Macdonald IA; van Ommen B; Smilde AK
    Anal Chem; 2006 Jan; 78(2):567-74. PubMed ID: 16408941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR and MS methods for metabonomics.
    Dieterle F; Riefke B; Schlotterbeck G; Ross A; Senn H; Amberg A
    Methods Mol Biol; 2011; 691():385-415. PubMed ID: 20972767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics study on quality control and discrimination of three curcuma species based on gas chromatograph-mass spectrometry.
    Xiang Z; Wang XQ; Cai XJ; Zeng S
    Phytochem Anal; 2011; 22(5):411-8. PubMed ID: 21433157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry-based metabolomics of yeast.
    Crutchfield CA; Lu W; Melamud E; Rabinowitz JD
    Methods Enzymol; 2010; 470():393-426. PubMed ID: 20946819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated GC-MS and LC-MS plasma metabonomics analysis of ankylosing spondylitis.
    Gao P; Lu C; Zhang F; Sang P; Yang D; Li X; Kong H; Yin P; Tian J; Lu X; Lu A; Xu G
    Analyst; 2008 Sep; 133(9):1214-20. PubMed ID: 18709197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of two-dimensional LC-MS with multivariate statistics for comparative analysis of proteomic samples.
    Gaspari M; Verhoeckx KC; Verheij ER; van der Greef J
    Anal Chem; 2006 Apr; 78(7):2286-96. PubMed ID: 16579610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations.
    Chen J; Wang W; Lv S; Yin P; Zhao X; Lu X; Zhang F; Xu G
    Anal Chim Acta; 2009 Sep; 650(1):3-9. PubMed ID: 19720165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time alignment algorithms based on selected mass traces for complex LC-MS data.
    Christin C; Hoefsloot HC; Smilde AK; Suits F; Bischoff R; Horvatovich PL
    J Proteome Res; 2010 Mar; 9(3):1483-95. PubMed ID: 20070124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple data-reduction method for high-resolution LC-MS data in metabolomics.
    Scheltema R; Decuypere S; Dujardin J; Watson D; Jansen R; Breitling R
    Bioanalysis; 2009 Dec; 1(9):1551-7. PubMed ID: 21083103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of peak picking quality in LC-MS metabolomics data.
    Brodsky L; Moussaieff A; Shahaf N; Aharoni A; Rogachev I
    Anal Chem; 2010 Nov; 82(22):9177-87. PubMed ID: 20977194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy.
    Zhu C; Liang QL; Hu P; Wang YM; Luo GA
    Talanta; 2011 Sep; 85(4):1711-20. PubMed ID: 21872008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MetAlign: interface-driven, versatile metabolomics tool for hyphenated full-scan mass spectrometry data preprocessing.
    Lommen A
    Anal Chem; 2009 Apr; 81(8):3079-86. PubMed ID: 19301908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry-based technologies for high-throughput metabolomics.
    Han J; Datla R; Chan S; Borchers CH
    Bioanalysis; 2009 Dec; 1(9):1665-84. PubMed ID: 21083110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.